AXA Investment Managers’s Gilead Sciences GILD Stock Holding History

AXA Investment Managers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$184M	Buy	+1,658,519	New	+$189M	0.5%	38

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AXA Investment Managers's GILD Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Gilead Sciences (GILD) in Q3 2025: 1,658,519 shares worth $184M. The stake represents 0.5% of the portfolio and ranks #38 among its holdings.

2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

AXA Investment Managers held 1,658,519 shares of Gilead Sciences worth $184M as of Q3 2025.
Gilead Sciences was a new AXA Investment Managers position in Q3 2025.
Gilead Sciences made up 0.5% of AXA Investment Managers's portfolio in Q3 2025, its #38 holding.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.